Top Biotechnology & Medical Research stocks in North America
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
VKTXViking Therapeutics | $8.19bn | n/a | n/a |
ASNDAscendis Pharma A/S | $7.84bn | n/a | n/a |
CERECerevel Therapeutics Holdings | $7.71bn | n/a | n/a |
EXELExelixis | $6.99bn | 36.67 | n/a |
CYTKCytokinetics | $6.83bn | n/a | n/a |
PCVXVaxcyte | $6.60bn | n/a | n/a |
RETAReata Pharmaceuticals | $6.52bn | n/a | n/a |
IONSIonis Pharmaceuticals | $6.07bn | n/a | n/a |
RVMDRevolution Medicines | $5.92bn | n/a | n/a |
BPMCBlueprint Medicines | $5.84bn | n/a | n/a |
ISEEIVERIC bio | $5.51bn | n/a | n/a |
IBRXImmunitybio | $4.95bn | n/a | n/a |
HALOHalozyme Therapeutics | $4.90bn | 18.25 | n/a |
CRSPCrispr Therapeutics AG | $4.58bn | n/a | n/a |
KRYSKrystal Biotech | $4.47bn | n/a | n/a |
SYNHSyneos Health | $4.46bn | 28.55 | n/a |
NUVLNuvalent | $4.28bn | n/a | n/a |
ALPNAlpine Immune Sciences | $4.23bn | n/a | n/a |
ALKSAlkermes | $4.18bn | 7.99 | n/a |
MRTXMirati Therapeutics | $4.12bn | n/a | n/a |